VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo
EAElizabeth A. HarringtonDBDavid BebbingtonJRJeffrey R. MooreRKRichele K. RasmussenAOAbi O Ajose-Adeogun
Vertex Pharmaceuticals (United Kingdom) · Vertex Pharmaceuticals (United States) · +2 more institutions
Indexed incrossrefdatacitepubmed
Abstract
No abstract available for this paper.
Citation impact
953
total citations
- FWCI
- 23.94
- Percentile
- 100%
- References
- 46
Citations per year
Authors
13- EAElizabeth A. HarringtonCorresponding
Vertex Pharmaceuticals (United Kingdom)
- DBDavid Bebbington
Vertex Pharmaceuticals (United Kingdom), Vertex Pharmaceuticals (United States)
- JRJeffrey R. Moore
Vertex Pharmaceuticals (United Kingdom), Vertex Pharmaceuticals (United States)
- RKRichele K. Rasmussen
Vertex Pharmaceuticals (United Kingdom), Vertex Pharmaceuticals (United States)
- AOAbi O Ajose-Adeogun
Vertex Pharmaceuticals (United Kingdom), Vertex Pharmaceuticals (United States)
Topics & keywords
Topics
Keywords
- Aurora inhibitor
- Kinase
- In vivo
- Cancer research
- Cytokinesis
- Aurora kinase
- Mitosis
- Biology
No related works found for this paper.